• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1

CATEGORIES

  • 1

PRICE

0
0
0
1

PUBLISHED

0
0
1
1

PRODUCT TYPE

1

Search "Harrisburg, PA Market Overview" returned 1 results.

PRODUCT TITLE
Hepatitis C: Game Changing Regimens to Revolutionise Treatment Landscape - KOL Insight Hepatitis C: Game Changing Regimens to Revolutionise Treatment Landscape - KOL Insight - Product Thumbnail Image

Hepatitis C: Game Changing Regimens to Revolutionise Treatment Landscape - KOL Insight

The December 2013 approval of Gilead's once daily oral nucleotide inhibitor Sovaldi marks a significant step in the treatment of hepatitis C (HCV) With efficacy over 90% in GT1/2/3/4 patients, this...

December 2013
FROM
Loading Indicator